Report cover image

Global Multiple Sclerosis Therapeutics Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750279

Description

Global Multiple Sclerosis Therapeutics Databank Market Report


The Multiple Sclerosis Therapeutics market was valued at $12,659.6 Million in 2020, and is projected to reach $22,745.4 Million by 2029 growing at a CAGR of 6.77% from 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. Small-molecule Drugs and Large-molecule Drugs segments are expected to witness significant growth rates at a CAGR of 7.38% and 6.10% respectively, during the forecast period.

Table of Contents

100 Pages
1. Global Multiple Sclerosis Therapeutics Market, By Route
1.1. Overview
1.2. Oral
1.2.1 Oral Market, By Region
1.2.1.1 North America Oral Market, By Country
1.2.1.2 Europe Oral Market, By Country
1.2.1.3 Asia-Pacific Oral Market, By Country
1.2.1.4 Rest of World Oral Market, By Country
1.3. Injectable and Others
1.3.1 Injectable and Others Market, By Region
1.3.1.1 North America Injectable and Others Market, By Country
1.3.1.2 Europe Injectable and Others Market, By Country
1.3.1.3 Asia-Pacific Injectable and Others Market, By Country
1.3.1.4 Rest of World Injectable and Others Market, By Country
2. Global Multiple Sclerosis Therapeutics Market, By Type
2.1. Overview
2.2. Large-molecule Drugs
2.2.1 Large-molecule Drugs Market, By Region
2.2.1.1 North America Large-molecule Drugs Market, By Country
2.2.1.2 Europe Large-molecule Drugs Market, By Country
2.2.1.3 Asia-Pacific Large-molecule Drugs Market, By Country
2.2.1.4 Rest of World Large-molecule Drugs Market, By Country
2.3. Small-molecule Drugs
2.3.1 Small-molecule Drugs Market, By Region
2.3.1.1 North America Small-molecule Drugs Market, By Country
2.3.1.2 Europe Small-molecule Drugs Market, By Country
2.3.1.3 Asia-Pacific Small-molecule Drugs Market, By Country
2.3.1.4 Rest of World Small-molecule Drugs Market, By Country
3. Global Multiple Sclerosis Therapeutics Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Multiple Sclerosis Therapeutics Market, By Route
3.2.2 North America Multiple Sclerosis Therapeutics Market, By Type
3.2.3 North America Multiple Sclerosis Therapeutics Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Multiple Sclerosis Therapeutics Market, By Route
3.2.3.1.2 U.S. Multiple Sclerosis Therapeutics Market, By Type
3.2.3.2 Canada
3.2.3.2.1 Canada Multiple Sclerosis Therapeutics Market, By Route
3.2.3.2.2 Canada Multiple Sclerosis Therapeutics Market, By Type
3.2.3.3 Mexico
3.2.3.3.1 Mexico Multiple Sclerosis Therapeutics Market, By Route
3.2.3.3.2 Mexico Multiple Sclerosis Therapeutics Market, By Type
3.3. Europe
3.3.1 Europe Multiple Sclerosis Therapeutics Market, By Route
3.3.2 Europe Multiple Sclerosis Therapeutics Market, By Type
3.3.3 Europe Multiple Sclerosis Therapeutics Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Multiple Sclerosis Therapeutics Market, By Route
3.3.3.1.2 Germany Multiple Sclerosis Therapeutics Market, By Type
3.3.3.2 France
3.3.3.2.1 France Multiple Sclerosis Therapeutics Market, By Route
3.3.3.2.2 France Multiple Sclerosis Therapeutics Market, By Type
3.3.3.3 U.K.
3.3.3.3.1 U.K. Multiple Sclerosis Therapeutics Market, By Route
3.3.3.3.2 U.K. Multiple Sclerosis Therapeutics Market, By Type
3.3.3.4 Italy
3.3.3.4.1 Italy Multiple Sclerosis Therapeutics Market, By Route
3.3.3.4.2 Italy Multiple Sclerosis Therapeutics Market, By Type
3.3.3.5 Spain
3.3.3.5.1 Spain Multiple Sclerosis Therapeutics Market, By Route
3.3.3.5.2 Spain Multiple Sclerosis Therapeutics Market, By Type
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Multiple Sclerosis Therapeutics Market, By Route
3.3.3.6.2 Rest of Europe Multiple Sclerosis Therapeutics Market, By Type
3.4. Asia-Pacific
3.4.1 Asia-Pacific Multiple Sclerosis Therapeutics Market, By Route
3.4.2 Asia-Pacific Multiple Sclerosis Therapeutics Market, By Type
3.4.3 Asia-Pacific Multiple Sclerosis Therapeutics Market, By Country
3.4.3.1 China
3.4.3.1.1 China Multiple Sclerosis Therapeutics Market, By Route
3.4.3.1.2 China Multiple Sclerosis Therapeutics Market, By Type
3.4.3.2 India
3.4.3.2.1 India Multiple Sclerosis Therapeutics Market, By Route
3.4.3.2.2 India Multiple Sclerosis Therapeutics Market, By Type
3.4.3.3 Japan
3.4.3.3.1 Japan Multiple Sclerosis Therapeutics Market, By Route
3.4.3.3.2 Japan Multiple Sclerosis Therapeutics Market, By Type
3.4.3.4 Australia
3.4.3.4.1 Australia Multiple Sclerosis Therapeutics Market, By Route
3.4.3.4.2 Australia Multiple Sclerosis Therapeutics Market, By Type
3.4.3.5 South Korea
3.4.3.5.1 South Korea Multiple Sclerosis Therapeutics Market, By Route
3.4.3.5.2 South Korea Multiple Sclerosis Therapeutics Market, By Type
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Multiple Sclerosis Therapeutics Market, By Route
3.4.3.6.2 Rest of Asia Multiple Sclerosis Therapeutics Market, By Type
3.5. Rest of World
3.5.1 Rest of World Multiple Sclerosis Therapeutics Market, By Route
3.5.2 Rest of World Multiple Sclerosis Therapeutics Market, By Type
3.5.3 Rest of World Multiple Sclerosis Therapeutics Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Multiple Sclerosis Therapeutics Market, By Route
3.5.3.1.2 Brazil Multiple Sclerosis Therapeutics Market, By Type
3.5.3.2 South Africa
3.5.3.2.1 South Africa Multiple Sclerosis Therapeutics Market, By Route
3.5.3.2.2 South Africa Multiple Sclerosis Therapeutics Market, By Type
3.5.3.3 GCC
3.5.3.3.1 GCC Multiple Sclerosis Therapeutics Market, By Route
3.5.3.3.2 GCC Multiple Sclerosis Therapeutics Market, By Type
3.5.3.4 RoW Countries
3.5.3.4.1 RoW Countries Multiple Sclerosis Therapeutics Market, By Route
3.5.3.4.2 RoW Countries Multiple Sclerosis Therapeutics Market, By Type
RoW Countries Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 2. Oral Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Oral Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Oral Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Oral Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Oral Market Value, By Country, 2020-2029, Million USD
TABLE 7. Injectable and Others Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America Injectable and Others Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe Injectable and Others Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific Injectable and Others Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World Injectable and Others Market Value, By Country, 2020-2029, Million USD
TABLE 12. Global Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 13. Large-molecule Drugs Market Value, By Region, 2020-2029, Million USD
TABLE 14. North America Large-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 15. Europe Large-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 16. Asia-Pacific Large-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 17. Rest of World Large-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 18. Small-molecule Drugs Market Value, By Region, 2020-2029, Million USD
TABLE 19. North America Small-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 20. Europe Small-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 21. Asia-Pacific Small-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 22. Rest of World Small-molecule Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 23. Global Multiple Sclerosis Therapeutics Market Value, By Region, 2020-2029, Million USD
TABLE 24. North America Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 25. North America Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 26. North America Multiple Sclerosis Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 27. U.S. Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 28. U.S. Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 29. Canada Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 30. Canada Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 31. Mexico Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 32. Mexico Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 33. Europe Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 34. Europe Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 35. Europe Multiple Sclerosis Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 36. Germany Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 37. Germany Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 38. France Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 39. France Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 40. U.K. Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 41. U.K. Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 42. Italy Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 43. Italy Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 44. Spain Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 45. Spain Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 46. Rest of Europe Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 47. Rest of Europe Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 48. Asia-Pacific Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 49. Asia-Pacific Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 50. Asia-Pacific Multiple Sclerosis Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 51. China Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 52. China Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 53. India Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 54. India Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 55. Japan Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 56. Japan Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 57. Australia Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 58. Australia Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 59. South Korea Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 60. South Korea Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 61. Rest of Asia Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 62. Rest of Asia Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 63. Rest of World Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 64. Rest of World Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 65. Rest of World Multiple Sclerosis Therapeutics Market Value, By Country, 2020-2029, Million USD
TABLE 66. Brazil Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 67. Brazil Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 68. South Africa Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 69. South Africa Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 70. GCC Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 71. GCC Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
TABLE 72. RoW Countries Multiple Sclerosis Therapeutics Market Value, By Route, 2020-2029, Million USD
TABLE 73. RoW Countries Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD
RoW Countries Multiple Sclerosis Therapeutics Market Value, By Type, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us